Blackrock owns 710k shares, Vanguard 270k shares. Of the institutions holdings, I believe they are the only ones who offer ETFs. I really wonder if it will be buying opportunity. Kopp (2.3M), Sabby (1.5M) Equtec (0.8M and Frigate (0.8M0 (other institutions with shares) could easily absorb shares if they wished.
Agree with most of your comments. Do you they will ultimately produce and sell or do you think company is hopeless?
Akonoway - has much insight into the company, former FDA trial, former mgmt and BoD. He's right in critiquing the new pumpers. He trades the stock, doesnt short it. He missed last leg up. I would not be surprised if he trades again (ie buys dip) I disagree with his statement that noone on this thread knows anything about company. TY Neal.
Sam love ya man. You are the bartender of this thread, You do have insight into the timing of products, expenses, cash needs and upside.
Melikes - admire your conviction and wish the BoD shared it. If company turns your investment strategy will be vindicated. Neal doesnt acknowledge this. Imagine investing $50k in a $20 stock that drops to $1 and then investing another $50k @ $1 per share. If stock goes back to $20, one makes $1M. I was able to quit day job years ago by investing in depressed stocks with turnaround potential Many stayed depressed but the multibaggers put me way ahead.
The purpose of the BoD is to represent shareholder interests. Are they?
The BoD of most large cap companies act responsibly and are held accountable. With small caps its hit and miss. The hits can become multibaggers. The misses not. I'm asking shareholders to join me in holding the BoD accountable - the first step is voting No and to withhold. I am only voting yes on the accountants.
The BoD has to prove something no me. Thus far they have proven lethargy. Stoll has connections with leading European companies that have not been harvested. The new members were hired for their financial connections. Unless they show me the money, I vote no and to withhold and embrace the shareholders to join me. The onus is clearly on the BoD
Recent upbeat news is SOLELY a result of dedicated company employees. They and shareholders deserve a better BoD - with skin in the game, proactive to arrange analyst coverage, proactive to arrange cash generating deals with BP or B Med Device makers. Thus far the BoD has done none of this. Show them the door.
you are right. but neither did PCYC until it did and then became 400 bagger from low to high. the basis for my comments for a more aggressive BoD - that is the missing link. it really looks like the technology is working and the basis for the safety concerns has been addressed by improved filter.
possible but will take time. for example of turnaround that took years - PCYC went from $80 high to 55 cent low to $200+ over years. during low phase nearly everyone thought it was dead - except Bob Duggan - entreprenur who invested his own money ($13M) and arranged partnership. He recently sold out his share for $3 B
Imo, they were advising clients who participated in offering to sell stock and keep warrants, locking in profits on the units (which were originally offered at 0.55) while keeping warrants as free lottery ticket to particpate in upside.
initial dabble around $2, then $1.50, then aggressively at and below $1. i'm up. sold portion today to lock in profits and plan to buy inevitable dips after current excitement subsides
a normal stock would be much higher on that volume relative to float. my guess is PIPE is done deal to be announced after close or before open. strictly a wag on my part
Biotech and Med device, esp small cap, is about clinical trials and cash. The BoD has huge responsibility in the latter area. The employees are to be commended, the BoD is failing in its responsibility to raise cash at reasonable price - ideally via deal and milestone payments, second choice is getting respected fund (BVF partners, RA capital, etc) to invest.